EG13530A - A process for preparing imidazolderivates - Google Patents

A process for preparing imidazolderivates

Info

Publication number
EG13530A
EG13530A EG554/78A EG55478A EG13530A EG 13530 A EG13530 A EG 13530A EG 554/78 A EG554/78 A EG 554/78A EG 55478 A EG55478 A EG 55478A EG 13530 A EG13530 A EG 13530A
Authority
EG
Egypt
Prior art keywords
imidazolderivates
preparing
preparing imidazolderivates
Prior art date
Application number
EG554/78A
Other languages
English (en)
Inventor
Anna Krasso
Ernest P Kraps
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of EG13530A publication Critical patent/EG13530A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG554/78A 1977-09-19 1978-09-13 A process for preparing imidazolderivates EG13530A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78140 1977-09-19
CH814978 1978-07-28

Publications (1)

Publication Number Publication Date
EG13530A true EG13530A (en) 1981-12-31

Family

ID=25702876

Family Applications (1)

Application Number Title Priority Date Filing Date
EG554/78A EG13530A (en) 1977-09-19 1978-09-13 A process for preparing imidazolderivates

Country Status (36)

Country Link
US (2) US4182766A (xx)
EP (1) EP0001279B1 (xx)
JP (1) JPS5459274A (xx)
AR (1) AR224350A1 (xx)
AT (1) AT368152B (xx)
AU (1) AU519711B2 (xx)
BG (1) BG28708A3 (xx)
BR (1) BR7806148A (xx)
CA (1) CA1106849A (xx)
DD (1) DD138210A5 (xx)
DE (2) DE2840591A1 (xx)
DK (1) DK406578A (xx)
EG (1) EG13530A (xx)
ES (1) ES473451A1 (xx)
FI (1) FI64365C (xx)
FR (1) FR2403340A1 (xx)
GB (1) GB2004281B (xx)
GR (1) GR73069B (xx)
HU (1) HU176111B (xx)
IE (1) IE47363B1 (xx)
IL (1) IL55557A (xx)
IN (1) IN148930B (xx)
IT (1) IT1098858B (xx)
MC (1) MC1213A1 (xx)
MT (1) MTP835B (xx)
NL (1) NL7809529A (xx)
NO (1) NO149962C (xx)
NZ (1) NZ188405A (xx)
OA (1) OA06054A (xx)
PH (1) PH16342A (xx)
PL (1) PL114494B1 (xx)
PT (1) PT68573A (xx)
RO (1) RO75258A (xx)
SE (1) SE7809792L (xx)
SU (1) SU793390A3 (xx)
YU (1) YU216778A (xx)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
HU193408B (en) * 1983-05-03 1987-10-28 Byk Gulden Lomberg Chem Fqb Process for production of new tree-cycle compounds
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
CA1341314C (en) * 1984-07-06 2001-11-06 David Cox Derivatives of benzimidazole, benzothiazole and benzoxazole
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
EP0204215B1 (en) 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
EP0649305A1 (en) * 1992-07-08 1995-04-26 Monsanto Company Benzimidazoles for alleviating stomach ulcers in swine
WO1995029897A1 (en) 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
NZ318501A (en) * 1995-09-21 1999-06-29 Pharma Pass Llc Novel composition containing an acid-labile omeprazole and process for its preparation
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (xx) * 1968-10-21 1971-06-03
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

Also Published As

Publication number Publication date
PH16342A (en) 1983-09-05
AU519711B2 (en) 1981-12-17
ES473451A1 (es) 1979-05-01
IE781878L (en) 1979-03-19
IN148930B (xx) 1981-07-25
NO149962C (no) 1984-07-25
IT1098858B (it) 1985-09-18
SE7809792L (sv) 1979-03-20
DE2861237D1 (en) 1981-12-10
IL55557A (en) 1982-02-28
FI64365B (fi) 1983-07-29
BR7806148A (pt) 1979-04-17
FR2403340A1 (fr) 1979-04-13
OA06054A (fr) 1981-06-30
PT68573A (fr) 1978-10-01
IL55557A0 (en) 1978-12-17
HU176111B (en) 1980-12-28
AU3981778A (en) 1980-03-20
ATA673378A (de) 1982-01-15
NL7809529A (nl) 1979-03-21
RO75258A (ro) 1980-11-30
US4248880A (en) 1981-02-03
NO149962B (no) 1984-04-16
MTP835B (en) 1979-11-14
FI64365C (fi) 1983-11-10
GR73069B (xx) 1984-01-30
MC1213A1 (fr) 1979-05-18
CA1106849A (en) 1981-08-11
NZ188405A (en) 1981-03-16
GB2004281A (en) 1979-03-28
IE47363B1 (en) 1984-03-07
EP0001279B1 (de) 1981-09-30
DK406578A (da) 1979-03-20
NO783155L (no) 1979-03-20
US4182766A (en) 1980-01-08
PL209693A1 (pl) 1979-06-04
DE2840591A1 (de) 1979-03-29
DD138210A5 (de) 1979-10-17
FI782847A (fi) 1979-03-20
AR224350A1 (es) 1981-11-30
SU793390A3 (ru) 1980-12-30
AT368152B (de) 1982-09-27
IT7827861A0 (it) 1978-09-19
YU216778A (en) 1983-01-21
FR2403340B1 (xx) 1981-02-13
PL114494B1 (en) 1981-01-31
BG28708A3 (en) 1980-06-16
GB2004281B (en) 1982-03-10
EP0001279A1 (de) 1979-04-04
JPS5459274A (en) 1979-05-12

Similar Documents

Publication Publication Date Title
EG13530A (en) A process for preparing imidazolderivates
GB2004493B (en) Process for preparing aluminus
GB2011899B (en) Process for preparing vincadifformine
HU179428B (en) Process for preparing 1-acyl-2-cyano-aziridines
JPS53124206A (en) Process for preparing ethylfneglycol
HU179663B (en) Process for preparing d-alpha-aminoacids
HU179803B (en) Process for preparing glucopyranose-nitroso-carbamides
JPS53130612A (en) Process for preparing ethlenfglycoldimethylether
JPS53105426A (en) Process for preparing acylcyanate
DE2860177D1 (en) Process for preparing acetylaminobenzenes
JPS53124212A (en) Process for preparing 33methyll22butenee11ol
GB2012756B (en) Process for preparing 5-arylhydantoins
DE2860421D1 (en) Process for preparing 1-amino-2-sulfo-4-bromanthraquinone
JPS53130615A (en) Process for preparing monochloropinacoline
JPS53121750A (en) Process for preparing naphtylaminehydroxysulfonate
PH15353A (en) A process for 2-chlorosulfinylazetidin-4-ones
DE2860171D1 (en) Process for preparing 1-amino-2-sulfo-4-bromo-anthraquinone
JPS53105423A (en) Process for preparing alphaaketocarboxylate
IL54521A0 (en) A process for preparing thiopheols
JPS53112813A (en) Process for preparing diinnpropylacetonitrile
IL54355A (en) Process for preparing 2-hydroxy-benzothiazole
IL55072A0 (en) Process for preparing butyl-p-benzoylbenzoates
JPS5395913A (en) Process for preparing tetraalkylthiuramdisulfide
JPS53112805A (en) Process for preparing diinnpropylacetamide
JPS53130616A (en) Process for preparing monohalogenoketone